top of page
Avibela Harmonized Labeling Initiative Final Brief
mirena plain background_edited.jpg

Harmonizing pharmaceutical product labeling (i.e., using identical labeling across multiple countries) can create time and cost efficiencies that benefit stakeholders across the value chain. Under the LEAP Initiative, Impact RH360, WCG Cares, and FHI 360 developed a strategy to implement harmonized labeling for the hormonal IUD, Avibela. The project team is disseminating the learnings from this project to enable other suppliers to implement harmonized labeling for their products, if desired.

Authors: Impact RH360, FHI 360, WCG

View the resource
bottom of page